Chancellor Reeves Plans Specific Action on Living Costs in Upcoming Financial Plan
Chancellor Rachel Reeves has stated she is planning "focused measures to tackle household expense issues" in the forthcoming financial statement.
Speaking to the BBC, she stated that reducing inflation is a shared duty of both the government and the central bank.
The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven industrialized countries this calendar year and next.
Potential Energy Bill Interventions
Reports indicate the administration could intervene to reduce energy bills, for example by slashing the current 5% level of VAT applied on energy supplies.
A further approach is to lower some of the government charges presently included in bills.
Fiscal Limitations and Analyst Expectations
The administration will receive the latest assessment from the official forecaster, the OBR, on Monday, which will show how much scope there is for such actions.
The view from the majority of analysts is that Reeves will have to announce tax rises or spending cuts in order to adhere to her self-imposed fiscal targets.
Earlier on Thursday, calculations showed there was a £22 billion deficit for the Treasury chief to fill, which is at the lower end of expectations.
"It is a joint task between the central bank and the administration to bear down further on some of the causes of inflation," Reeves told reporters in Washington, at the annual meetings of the International Monetary Fund and World Bank.
Revenue Pledges and Global Issues
While a great deal of the attention has been on expected tax increases, the chancellor said the most recent figures from the fiscal watchdog had not altered her commitment to manifesto promises not to increase tax levels on income tax, VAT or social security contributions.
She blamed an "uncertain global environment" with growing international and trade concerns for the Budget tax moves, likely to be targeted on those "wealthiest."
International Trade Disputes
Commenting on worries about the United Kingdom's trade ties with the Asian nation she said: "Our national security always are paramount."
Recent declaration by Chinese authorities to increase export controls on rare earths and other materials that are essential for advanced tech manufacturing led US President Donald Trump to suggest an additional 100% import tax on goods from the Asian country, increasing the prospect of an all-out trade war between the two economic giants.
The American finance chief described China's move "commercial pressure" and "a global supply chain control attempt."
Inquired about accepting the US offer to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and called on the Beijing authorities "not to put up barriers and limit trade."
She said the action was "harmful for the global economy and generates further obstacles."
"In my view there are sectors where we should challenge Chinese policies, but there are also valuable opportunities to export to China's economy, including financial services and other areas of the economic system. We've got to achieve that balance correct."
The chancellor also affirmed she was collaborating with G7 counterparts "regarding our own critical minerals strategy, so that we are less reliant."
Health Service Drug Pricing and Investment
The Chancellor also recognized that the price the National Health Service spends on pharmaceuticals could rise as a result of ongoing discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.
Some of the biggest global drug companies have said lately that they are either delaying or canceling projects in the UK, with several blaming the modest returns they are obtaining.
Last month, the government science advisor said the price the health service pays for drugs would have to rise to halt businesses and pharmaceutical investment leaving the United Kingdom.
Reeves told the BBC: "It has been observed because of the cost structure, that clinical trials, new drugs have not been provided in the United Kingdom in the extent that they are in other EU nations."
"We want to make sure that people receiving care from the National Health Service are able to obtain the best essential treatments in the globe. And so we are reviewing all of that, and... seeking to secure increased capital into the UK."